Staff Directory
Academic Qualification
- Ph.D in Pharmaceutical Sciences - Doctor of Philosophy, University of Strathclyde
- Bachelor of Science in Pharmacy - Bachelor Degree, University of Strathclyde
- Pharmaceutical Sciences - Certificate, International Medical University (IMC) Petaling Jaya
Farahidah Binti Mohamed (Assoc. Prof. Dr.)
Associate Professor
IIUM Kuantan Campus
KULLIYYAH OF PHARMACY
farahidah@iium.edu.my
4843
Expert Profile
Assoc. Professor Dr. Farahidah Mohamed obtained her BSc.in Pharmacy from Strathclyde University in 1999 and subsequently worked in community pharmacies and government hospitals before deciding to pursue a PhD in 2004. She successfully completed her PhD from Strathclyde Institute of Pharmacy and Biomedical Sciences in Scotland in 2008. Throughout her career, she has been actively involved in leading various research projects funded by different agencies and ministries. Her expertise has been recognised, and she has received industrial grants to coordinate Good Manufacturing Practice (GMO)-associated training. Additionally, she has an impressive academic presence, having participated in over 30 international conferences and published more than 30 papers in reputable journals. She has also supervised more than 17 postgraduate master’s and PhD students, contributing to the development of future researchers in the field. As a Principal Investigator, Dr. Farahidah has secured research grants totaling RM 2.4 million for nine research projects. Her current focus lies in the design of various dosage forms that combine contemporary medicine with prophetic, natural, or traditional products. The aim of her research is to create synergistic effects, reduce toxicity, improve treatment compliance and decrease overall treatment costs. Her effort has resulted in the successful commercialization of five products, ranging from healthcare to pharmaceutical products, with a cumulative revenue of about RM 6 million. She has been recognised with numerous awards for her contributions to the field. Notably, she received the prestigious Gold Award at the Malaysia Technology Expo and a Special Award from ISPE (Malaysia Chapter) for her innovation in developing a greener pharmaceutical product, specifically paracetamol-honey in 2022. She has also been invited to speak at various platforms, including the Ministry of Health, universities and international events.
Dr. Farahidah has had significant experience and responsibilities in the field of pharmaceutical manufacturing. As Head of Department of Production (2012-2014), she was responsible for overseeing the production department of IKOP Pharma Sdn. Bhd. (formerly known as IKOP Sdn. Bhd.) including managing the production process, ensuring compliance with regulations and standards, coordinating with other departments and supervising staff. As Acting Chief Executive Officer (CEO) (2014-2020), she had overall leadership and management responsibilities for IKOP Pharma Sdn. Bhd. This involved making strategic decisions, managing operations, overseeing financial aspects, representing the company to external stakeholders, and driving the company’s growth and success. Her involvement in GMP indicates her expertise in regulatory compliance, quality management systems and ensuring adherence to industry best practices. She also acquired technical skills in the industry such as scaling up pharmaceutical manufacturing process which involved transitioning from laboratory-scale to commercial-scale production. This requires expertise in optimizing and adapting processes, ensuring consistent quality and addressing challenges associated with large-scale production. Additionally, she was also competent in process qualification for various dosage forms indicating her proficiency in developing and ensuring the reliability and robustness of manufacturing processes for different types of dosage forms. Another aspect of pharmaceutical GMP is the performance qualification that she has acquired during her tenure at IKOP Pharma Sdn. Bhd. This suggests her ability to design and execute qualification protocols, assess equipment performance, and ensure compliance with regulatory requirements. August 2021-July 2023, she was holding Deputy Director post at IIUM Technology Transfer Office (TTO), Research Management Centre at IIUM to spearhead the income generation of the university via commercialisation of IIUM Intellectual Properties.
In 2022, she expanded her techno-preneurial endeavours by launching a herbal coffee product called “STEKO”, aimed at promoting weight loss. Additionally, she is the founder of the “ObiReverse”, a Community Engagement Program advocating for the belief that obesity can be reversed. She continues to make significant contributions to the fields of pharmacy and biomedical sciences, bridging contemporary and traditional approaches to improve healthcare outcomes and promote sustainable practices.
Area of Specialisation
- Engineering Tech ~ Applied Sciences And Technologies ~ Nanotechnology ~ Other Nanotechnology n.e.c.
- Biotechnology ~ Biotechnology ~ Biopharmacy Biotechnology ~ Biopharmaceuticals
- Biotechnology ~ Biotechnology ~ Medical Biotechnology ~ Gene Therapy
- Medical And Health ~ Medical And Health Sciences ~ Pharmacy ~ Pharmaceutical Technology
- Medical And Health ~ Medical And Health Sciences ~ Pharmacy ~ Drug Discovery - Drug Delivery
Professional Membership
- 2015 - 2015: Member of Profesional Body / Association: (Member), International Society for Pharmaceutical Engineering
- 2015: Member of Profesional Body / Association: (Life member), Malaysian Pharmaceutical Society
- 2015 - 2040: Member of Profesional Body / Association: (Life member), Malaysian Pharmaceutical Society
Teaching Responsibilities
| ADVANCED DRUG DELIVERY SYSTEM | 2014/2015 2013/2014 |
| BIOPHARMACEUTICALS | 2013/2014 2010/2011 |
| DOSAGE DESIGN I | 2019/2020 2018/2019 2013/2014 2011/2012 2010/2011 2009/2010 2008/2009 |
| DOSAGE DESIGN II | 2020/2021 2019/2020 2018/2019 2016/2017 2015/2016 2014/2015 2013/2014 2012/2013 2011/2012 2010/2011 2009/2010 |
| DRUG DELIVERY AND TARGETING | 2014/2015 2013/2014 |
| Drug Delivery System | 2012/2013 2011/2012 2010/2011 |
| DRUG DELIVERY SYSTEMS | 2009/2010 |
| FINAL YEAR RESEARCH PROJECT | 2022/2023 |
| HALAL PHARMACEUTICAL | 2020/2021 |
| INDUSTRIAL PHARMACY | 2021/2022 2020/2021 2019/2020 2018/2019 2017/2018 2016/2017 2015/2016 2014/2015 2013/2014 |
| INDUSTRIAL PHARMACY AND REGULATIONS | 2010/2011 2009/2010 |
| INDUSTRIAL TRAINING | 2022/2023 |
| ISLAMIC INPUT IN PHARMACY | 2015/2016 |
| PHARMACEUTICAL BIOTECHNOLOGY & BIOPHARMACEUTICAL | 2021/2022 2015/2016 2014/2015 2013/2014 |
| PHARMACEUTICS I : PHYSICOCHEMICAL PRINCIPLES | 2022/2023 2021/2022 2020/2021 |
| PHARMACEUTICS III : SOLIDS AND OTHER DOSAGE FORMS | 2022/2023 2021/2022 2020/2021 |
| Pharmacokinetics and Biopharmaceutics | 2010/2011 2008/2009 |
| PHARMACY MANAGEMENT AND ADMINISTRATION | 2020/2021 |
| Physical Pharmacy II | 2009/2010 |
| QUALITY CONTROL | 2013/2014 |
| RESEARCH PROJECT 1 | 2016/2017 2014/2015 2013/2014 |
| RESEARCH PROJECT 2 | 2014/2015 |
| RESEARCH PROJECT-LITERATURE SEARCH | 2014/2015 2013/2014 2012/2013 |
| STERILE PRODUCT SYSTEMS | 2014/2015 |
Research Projects
Completed
| 2022 - 2023 | Botanical Identification and Evaluation of Metabolite Profile of Labi-labi Leaves using Gas Chromatography-mass Spectrometry, Liquid Chromatography-mass Spectrometry, and Fourier Transformed-infra Red Spectroscopy |
| 2021 - 2023 | Pre-Commercialisation and Commercialisation of Herbal Coffee for Weight Management |
| 2018 - 2022 | Black Seed Oil Alginate Beads |
| 2018 - 2020 | Reproducible Preparation of Thymoquinone Nanoparticles Using Electrospray |
| 2017 - 2022 | Naso-mucosal absorption of neuronal drug by sol-to-gel delivery system to target brain: approach to dose reduction |
| 2016 - | Safety and Efficacy of Oral Emulsion and Implanted Beads of N. sativa-Gentamicin Antibiofilm Fusion for Osteomyelitis |
| 2016 - 2022 | Antibiofilm and remineralisation study of novel, nano-fusion antibiotic paste for periodontitis |
| 2016 - 2020 | Development and Formulation of a fixed dose combination of carbamazepine and gabapentin a Novel Approach to Increase Therapeutic efficacy for Peripheral Neuropathic Pain in Diabetic Patient |
| 2015 - 2019 | Tumor suppressor p73?-loaded PLGA/chitosan/Nigella sativa nanoparticles: A novel non-viral gene delivery system for oral squamous cell carcinoma therapy |
| 2015 - 2017 | Pilot Scale Production of Natural Halal Skin Lightening Cream Containing Extract of Hydroxychavicol from Piper betle Leaves |
| 2013 - 2017 | Fusion Prophetic Medicine (Honey) and Contemporary Medicine (Paracetamol) as a Future Greener Pharmaceutical |
| 2013 - 2016 | TRANS DISCIPLINARY PROGRAM: MAIN TITLE: FUSION CONCEPT BETWEEN CONTEMPORARY MEDICINE (GENTAMICIN) AND PROPHETIC MEDICINE (N.SAATIVA) FOR FUTURE 'GREENER' PHARMACEUTICAL Project Title:Effect of Gentamicin-N.Sativa Fusion Medicine on Osteoblast Cell Lines for Use in Osteo-Healing Applications |
| 2013 - 2016 | Identification of Critical Elements for the Manufacturing of Halal Pharmaceuticals |
| 2013 - 2015 | TRANS DISCIPLINARY PROGRAM: MAIN TITLE: FUSION CONCEPT BETWEEN CONTEMPORARY MEDICINE (GENTAMICIN) AND PROPHETIC MEDICINE (N.SAATIVA) FOR FUTURE 'GREENER' PHARMACEUTICAL Project Title: Characterisation of Physiochemical Properties and Compatibility Testing of Gentamicin-N-Sativa Fusion |
| 2013 - 2015 | TRANS DISCIPLINARY PROGRAM (TRGS): MAIN TITLE: FUSION CONCEPT BETWEEN CONTEMPORARY MEDICINE (GENTAMICIN) AND PROPHETIC MEDICINE (N.SAATIVA) FOR FUTURE 'GREENER' PHARMACEUTICAL Project Title:Microbial Inhibition and Biofilm Assay Study Against Osteomyelitic Infection Using New Gentamicin-N.Sativa Fusion Medicine |
| 2011 - 2014 | Bio-equivalence Study of Generic Amlodipine Tablet (IIUM Pharmacy) and Brand-name Amlodipine Tablet in Healthy Human Volunteers |
| 2011 - 2013 | Comparative Study between Vegetarian Capsule and Bovine Hard Gelatin Capsule |
| 2011 - 2021 | Formulation and Development of Amlodipine Besylate 5mg and 10mg Tablets and Scale-up from Laboratory to Pilot Scale |
| 2011 - 2013 | Formulation and Testing of Syariah Compliant Generic Products (Amlodipine, Mefenamic Acid, Cetirizine, Gliclazide, Anti-Fungal Cream, Paracetamol Suspension) |
| 2011 - 2014 | Proof-of-concepts study of injectable non-viral gene delivery system of DNA-loaded N.Sativa/Chitosan/PLGA nanoparticle to neuro cell lines (Neurobionanoparticles-CR) |
| 2011 - 2014 | Bio-equivalence Study of Generic Cetirizine Tablet (IIUM Pharmacy)and Brand-Name Cetirizine Tablet in Healthy Male Volunteers |
| 2011 - 2014 | Bio-equivalence Study of Generic Gliclazide Tablet (IIUM Pharmacy) and Brand-name Gliclazide Tablet (Diamicron)in Healthy Male Volunteers |
| 2011 - 2014 | Bio-equivalence Study of Generic Mefenamic Acid Capsule (IIUM Pharmacy) and Brand-name Mefenamic Acid Capsule (Ponstan)in Healthy Male Volunteers |
| 2011 - 2014 | RU 2011 -Sythesis and characterization of Poly (D,L-lactide-Co-glycolide) based magnetic nanoparticles and to study their applications in drug delivery. |
| 2010 - 2013 | Comparative Study Between Bovine Hard Gelatin Capsule and Vegetarian Capsule |
| 2010 - 2012 | Microencapsulation of Cassia alata Extract for Topical Application. |
| 2010 - 2011 | Isolation and anticancer Evaluation of Mangostin from Garcinia Malaccensis |
| 2010 - 2012 | Development of Micro-carrier System Using Chitosan-PLGA Microspheres for Transfection into Bone Cell Line |
| 2010 - 2012 | Neuroregenerative And Neuroprotective Properties Of Haruan Traditional Extract For The Treatment Of Traumatic Brain Damage In Sprague Dawley Rats |
| 2010 - 2012 | Formulation of Malaysian Tualang Honey as Intraarticular Injection for Osteoarthritis |
| 2009 - 2012 | Development of non-viral gene delivery system using chitosan PLGA microsphere for transfection on neuron cell line(s) |
On-Going
| 2022 - Present | Data Mining of Malay Medical Manuscripts and Construction of a Database of Malay Medicine With Interventions for Covid-19-like Symptoms As a Focus |
| 2022 - Present | OPTIMISATION AND FORMULATION OF SYNBIOTIC TOOTHPASTE |
| 2021 - Present | PREPARATION OF A CRITICAL EDITION OF KITAB TIB `MEL 090 KIT 07763?: A MALAY MEDICAL MANUSCRIPT FROM JOHOR |
| 2020 - Present | Prototype Development of Malaysian Tualang Honey as Intraarticular Viscosupplement for Osteoarthritis |
| 2020 - Present | Prototype for Multi-purpose Solution (MPS) of Contact Lenses with Advanced Formulation against Acanthamoeba (K-CARE). |
| 2019 - Present | Prototype development of process analytical technology (PAT) continuous production line for Nigella sativa oil (NSO)-alginate microparticles |
| 2019 - Present | Preparation, characterisation and cytotoxicity assay of damnacanthal-loaded polymeric nanocapsules for breast cancer therapy |
| 2019 - Present | Formulation and characterisation of micronized Oroxylum indicum intended for hepatoprotective effect based on Malay Medical Manuscript |
| 2018 - Present | Development of circuit simulator model for Negative Capacitance Field Effect Transistors for Low Power IoT Devices applications |
| 2017 - Present | Doxycycline Nanoemulsion |
| 2015 - Present | Prototype Development of Halal, Eco-Friendly Doxycycline-N sativa eugenol (DNE) Fusion as a novel Treatment for Periodontitis |
| 2014 - Present | Palm-olein based Betamethaone 17-valerate cream for skin disease |
| 2007 - Present | Advanced Delivery System Using Locally - Produces Implantable Antibiotics- Incorporated Apatite Beads For Bone Repair -BioDDS |
Award & Recognition
| 14 Nov, 2018 | Award for 15 Years of Service - International Islamic University Malaysia | University |
| 12 Jul, 2018 | Special Recognition Award - International Islamic University Malaysia | University |
| 09 Feb, 2011 | Gold - IIUM | University |
| 09 Feb, 2011 | Bronze - IIUM | University |
| 26 Nov, 2010 | Best Poster - Kulliyyah of Science, International Islamic University Malaysia | International |
| 27 Jan, 2010 | Bronze - IIUM | University |
| 09 Nov, 2005 | Best Poster - Scottish Microscopy Group | International |
Publications
Article
Conference or Workshop Item
Book Section
| 2018 | Alzheimer disease: gene therapy and natural product research. In: IIUM Press, International Islamic University Malaysia, ISBN: 978-967-418-454-4, pp. 175-198 |
| 2015 | Islamic perspectives on manufacturing of pharmaceuticals. In: IIUM Press, ISBN: 979-967-418-316-5, pp. 1-33 |
| 2015 | Islamic perspectives on manufacturing of pharmaceuticals. In: IIUM Press, ISBN: 979-967-418-316-5, pp. 1-33 |
| 2011 | Co-encapsulation of cyclophosphamide and mesna into double-walled microspheres. In: IIUM Press, ISBN: 9789674180751, pp. 77-96 |
| 2011 | Microencapsulation of gentamicin into PLGA-chitosan matrices. In: IIUM Press, ISBN: 9789674180195, pp. 112-128 |
| 2011 | MIcrospher-iiUM, a novel, controlled-released drug/gene delivery system. In: IIUM Press, ISBN: 978-983-3124-14-9, pp. 183 |